Acute cardiac care & resuscitation

External validation of organ perfusion pressure as a prognostic marker in cardiogenic shock

Am Heart JPublished retrospective analysis of a Multicenter International Registry

Authors' conclusion

In this multicenter CS cohort, admission OPP was an independent prognostic marker of in-hospital mortality, irrespective of underlying CS etiology. Its inherent simplicity and demonstrated clinical robustness may support its integration into risk stratification and CS protocols.

Study context

Population
Patients admitted for cardiogenic shock related to heart failure or acute myocardial infarction, July 2023 to October 2024patients considered
Participants
621 patients
Exposure
Admission organ perfusion pressure (OPP) as a predictor of in-hospital all-cause death
  • Nonsurvivorsn = 247
Outcome
In-hospital all-cause death
Follow-up
In-hospital
Methodological detailsconsecutive patients, external validation
  • Consecutive patients
  • External validation

Main finding

As reported in the abstract

Estimate (95% CI)P value
Low OPP (<57 mmHg)univariable; consistent across both AMI-CS and HF-CS cohorts
OR 3.20(2.25–4.56)
P < 0.001
Lower OPPmultivariable logistic regression
OR per mmHg decrease 1.03(1.01–1.06)
P = 0.020
In-hospital all-cause death
247 (39.8%)

Observational data: associations, not effects.

Further findings

Median, mmHg

OutcomeNonsurvivorsSurvivorsP value
OPP · admissionNonsurvivors vs survivors · significantly lower OPP in nonsurvivors59 (IQR 49–69)70 (IQR 60–80)P < 0.001

Baseline characteristics

Mean age
62 ± 13 years
Female
138 [22.2%]
SCAI stage ≥ C severity
518 (83.4%)

Model performance of OPP for in-hospital mortality

C-index
0.691
Slope
1.01
Intercept
0.01

Original publication

External validation of organ perfusion pressure as a prognostic marker in cardiogenic shock. Am Heart J. Published 17 April 2026. doi:10.1016/j.ahj.2026.107448

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.